Company / Income Tax
BeOne Medicines Ltd. Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$129.9M
FY2025
5-year range
$19.2M / $129.9M
FY2021-FY2025
Trend
+16.2%
vs FY2024
Sector context
#20 of 204
Health Care
What the data says
Among 204 Health Care companies, BeOne Medicines Ltd. is in the bottom 10% for income tax. Income Tax has increased for 7 consecutive years, from -$16M in FY2018 to $130M in FY2025.
Based on SEC 10-K filings.
$130M in FY2025 with a 5-year CAGR of +65.7%. Top quartile in the Health Care sector.
Increased from $56M to $130M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- +44.8%
- 5-Year CAGR
- +65.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 204This company $129.9M Sector average $118.7M
▼
+9.4% above sector average
Key checks
Key Insights
- BeOne Medicines Ltd.'s income tax has grown for 7 consecutive years.
- 5-year CAGR of +65.7%, indicating consistent growth.
- In FY2025, income tax increased 16.2% year-over-year.
- Ranks #20 out of 204 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.82 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $129.9M | +16.2% |
| FY2024 | $111.8M | +100.1% |
| FY2023 | $55.9M | +30.6% |
| FY2022 | $42.8M | +122.5% |
| FY2021 | $19.2M | +84.9% |
| FY2020 | $10.4M | +48.7% |
| FY2019 | $7.0M | +144.3% |
| FY2018 | -$15.8M | -806.8% |
| FY2017 | $2.2M | +4038.9% |
| FY2016 | $54.0K | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026